
Sign up to save your podcasts
Or


All day, every day we are flooded with 2020 presidential election coverage, but rarely do we get a nuanced analysis of how a new or continued administration will impact policies most important to health systems. In Part 1 of Sg2 Perspective’s 2-part election series, we discuss one such policy as Vizient Senior Government Relations and Policy Director Steve Rixen joins Sg2’s Bill Woodson and Valinda Rutledge to discuss how a Trump administration or a Biden administration would likely address high drug costs and what that means for health system providers.
By Vizient4.7
4949 ratings
All day, every day we are flooded with 2020 presidential election coverage, but rarely do we get a nuanced analysis of how a new or continued administration will impact policies most important to health systems. In Part 1 of Sg2 Perspective’s 2-part election series, we discuss one such policy as Vizient Senior Government Relations and Policy Director Steve Rixen joins Sg2’s Bill Woodson and Valinda Rutledge to discuss how a Trump administration or a Biden administration would likely address high drug costs and what that means for health system providers.

228,914 Listeners

39,011 Listeners

21,165 Listeners

676 Listeners

31,772 Listeners

69,390 Listeners

2,445 Listeners

197 Listeners

10 Listeners

176 Listeners

29,218 Listeners

2,542 Listeners

4,498 Listeners

16,892 Listeners

1,424 Listeners